• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Paul Whelton Outlines the Importance of Out-of-Office Blood Pressure Measurements

Video

The time a patient is in a doctor's office represents a very small window of the body normally, which makes out-of-office blood pressure measurements important to confirm diagnosis of hypertension, explained Paul Whelton, MD, MSc, professor of global public health at Tulane University.

The time a patient is in a doctor's office represents a very small window of the body normally, which makes out-of-office blood pressure measurements important to confirm diagnosis of hypertension, explained Paul Whelton, MD, MSc, professor of global public health at Tulane University.

Transcript

The new hypertension guideline emphasizes the need for measuring blood pressure when patients are not in the physician's office. Why is this important?

The measurement is very important. Obviously, we're going to make key decisions to label somebody as having high blood pressure and to maybe instigate therapy—lifestyle or drugs. And so we emphasize accurate measurements of blood pressure. we emphasize getting the average estimate of blood pressure, and we emphasize out-of-office blood pressure measurements, because we realize that once you get in the office, there's a very narrow window of what the body sees. So, it's important to get out-of-office measures to confirm the diagnosis of hypertension in the office, and to recognize white coat hypertension, or to recognize, more importantly, masked hypertension.

So for all of those reasons, we've put a strong emphasis on out-of-office blood pressure measurements. And, of course, in the United States, that's mostly going to be home blood pressure measurements, so the patient needs to be instructed how to get accurate measuremnts.

Related Videos
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
"Integrating New PAH Therapies into Clinical Practice"
"Clinical Evidence for Emerging PAH Therapies"
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Screenshot of Angela Jia, MD, PhD, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.